Accéder au contenu
Merck

Automated Blood Sampling in a Canine Telemetry Cardiovascular Model.

Comparative medicine (2021-04-06)
Amanda S Wilsey, Yevgeniya E Koshman, Debra A Weisbecker, Brandan M Bird, Kuldip K Mirakhur, Sabine Sadilek, Paige A Ebert, James S Polakowski, C Michael Foley, Chris L Medina, Scott W Mittelstadt
RÉSUMÉ

Successful implementation of automated blood sampling (ABS) into a telemetry instrumented canine cardiovascular model provides simultaneous cardiovascular assessment of novel compounds while collecting multiple blood samples for analysis of drug level, cytokines, and biomarkers. Purpose-bred male Beagle dogs (n = 36) were instrumented with a dual-pressure telemetry transmitter and vascular access port. Modifications to acclimation practices, surgical procedures, and housing were required for implementation of ABS in our established cardiovascular canine telemetry colony. These modifications have increased the use and reproducibility of the model by combining early pharmacokinetic and cardiovascular studies, thus achieving both refinement and reduction from a 3R perspective. In addition, the modified model can shorten timelines and reduce the compound requirement in early stages of drug development. This telemetry-ABS model provides an efficient means to quickly identify potential effects on key cardiovascular parameters in a large animal species and to obtain a more complete pharmacokinetic-pharmacodynamic profile for discovery compounds.